| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
1 company
Robert J Adelman last filed a Form 4 in July 2020 for ALXO. Robert J Adelman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 99,406 shares of ALXO. Net of sales, the ALXO filings show accumulation of 853,000 shares.
Robert J Adelman has 1 Form 4 filing on record in July 2020, as Alx Oncology (ALXO), 2020.
The 5 reported transactions were 3 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $16.2M and no sales.
The only open-market purchase was 853,000 shares of ALXO at an average $19.00 on July 21, 2020, about $16.2M.
Shares as reported in the last Form 4 for each company; the most recent is from July 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2020 | ALXO Alx Oncology Holdings Inc | - | Buy | 853,000 | $19.00 | $16,207,000.00 | -113.2% |